|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 201 | Codon-Usage Optimization of gag, pol, env and nef Genes of an HIV-1 Subtype C Strain
F. Gao*, Y. Li, C.M. Rodenburg, Y. Chen, D.R. Shaw, A.J. Zajac, and B.H. Hahn Univ. of Alabama at Birmingham, USA |
| 203 | Engineered HIV-1 Subtype C Envelope Genes for Vaccine Applications
Y. Lian*1, Y. Sun1, L. Leung1, E. Kan1, A. Fong1, S. Engelbrecht2, F. Treurnicht2, J. zur Megede1, E. Janse van Rensburg2, I. Srivastava1, and S. W. Barnett1 1Chiron Corp., Emeryville, CA, USA and 2Univ. of Stellenbosch, South Africa |
| 204 | Effect of Rev Expression on SIVmac239 gp130 Env Genes in Mammalian Cells
D. D. Wu*, D. Chen, and R. Brown Quality Biological Inc., Gaithersburg, MD, USA |
| 205 | Improved Human Immunodeficiency Virus 1 Gag and Pol Expression Cassettes
J. zur Megede*, G. R. Otten, L. Leung, H. Liu, B. Doe, and S. W. Barnett Chiron Corp., Emeryville, CA, USA |
| 206 | Design and in Vitro Characterization of Clade AG and B DNA Vaccines for AIDS
J. Smith*1, D. Ellenberger2, B. Li2, W. Heneine2, S. Butera1, T. Folks2, and H. L. Robinson1 1Emory Vaccine Ctr., Emory Univ., Atlanta, GA, USA and 2CDC, Atlanta, GA, USA |
| 207 | Designing an HIV World Clade Vaccine Using a Bioinformatics-Based Approach
H. Sbai*1, J. Frost1, A. Bosma1, G. Skowron3, K. Mayer4, W. Martin2, and A. S. De Groot1,2 1TB/HIV Res. Lab, Brown Univ., Providence, RI, USA; 2EpiVax, Inc., Providence, RI, USA; 3 Roger Williams Hosp., Providence, RI, USA; and 4 Brown AIDS Program, Providence, RI, USA |
| 208 | Oligo-Arginine-Conjugated HIV-1 gag Induces Specific T-Cell Responses in HIV-Infected and Uninfected Individuals
S. K. Kundu-Raychaudhuri*1, J. Rothbard2, E. Engleman1, and T. C. Merigan1 1Stanford Univ. Med. Ctr., CA, USA and 2Cellgate Inc., Sunnyvale, CA, USA |
| 209 | PCR-Based Methods as an Alternative Tool for Generating Humanized Oligonucleotide
S. Sirivichayakul*, T. Tirawatnapong, K. Ruxrungtham, S. Lorenzen, R. Oelrichs, and P. Phanuphak Chulalongkorn Univ., Bangkok, Thailand |
| 210 | Potential Use of Macrophage-Tropic DNA-Enzymes to Inhibit HIV-1 Gene Expression
A. C. Banerjea* Natl. Inst. of Immunology, New Delhi, India |
| 211 | In Vitro Inhibition of Human Immunodeficiency Virus Type 1 ( HIV-1 ) by FOY and Glutathione Reductase
R. Ansovini*1, N. Vanden2, and M. Q. Arens2 1Perugia, Italy and 2Washington Univ. Med. Sch., St. Louis, MO, USA |